OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group
Bettina Jansko-Gadermeir, Michael Leisch, Franz Josef Gassner, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2305-2305
Open Access | Times Cited: 13
Bettina Jansko-Gadermeir, Michael Leisch, Franz Josef Gassner, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2305-2305
Open Access | Times Cited: 13
Showing 13 citing articles:
Diagnosis and classification of myelodysplastic syndromes
Robert P. Hasserjian, Ulrich Germing, Luca Malcovati
Blood (2023) Vol. 142, Iss. 26, pp. 2247-2257
Closed Access | Times Cited: 23
Robert P. Hasserjian, Ulrich Germing, Luca Malcovati
Blood (2023) Vol. 142, Iss. 26, pp. 2247-2257
Closed Access | Times Cited: 23
Clonal relapse dynamics in acute myeloid leukemia following allogeneic hematopoietic cell transplantation
Clara Wienecke, Bennet Heida, Letizia Venturini, et al.
Blood (2024) Vol. 144, Iss. 3, pp. 296-307
Closed Access | Times Cited: 11
Clara Wienecke, Bennet Heida, Letizia Venturini, et al.
Blood (2024) Vol. 144, Iss. 3, pp. 296-307
Closed Access | Times Cited: 11
Do we Need to Perform Bone Marrow Examination in all Subjects Suspected of MDS ? Evaluation and Validation of Non‐Invasive (Web‐Based) Diagnostic Algorithm
Howard S. Oster, Ariel M. Polakow, Roi Gat, et al.
European Journal Of Haematology (2025)
Closed Access
Howard S. Oster, Ariel M. Polakow, Roi Gat, et al.
European Journal Of Haematology (2025)
Closed Access
cfDNA Chimerism and Somatic Mutation Testing in Early Prediction of Relapse After Allogeneic Stem Cell Transplantation for Myeloid Malignancies
Scott D. Rowley, Maher Albitar, Melissa Baker, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 625-625
Open Access
Scott D. Rowley, Maher Albitar, Melissa Baker, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 625-625
Open Access
Revisiting the Role of Day 14 Bone Marrow Biopsy in Acute Myeloid Leukemia
Omer Jamy, Garrett Bourne, Todd William Mudd, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 900-900
Open Access
Omer Jamy, Garrett Bourne, Todd William Mudd, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 900-900
Open Access
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee
Francesco Onida, Nico Gagelmann, Yves Chalandon, et al.
Blood (2024) Vol. 143, Iss. 22, pp. 2227-2244
Open Access | Times Cited: 2
Francesco Onida, Nico Gagelmann, Yves Chalandon, et al.
Blood (2024) Vol. 143, Iss. 22, pp. 2227-2244
Open Access | Times Cited: 2
Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patients
Sandra Huber, Natalie Wossidlo, Torsten Haferlach, et al.
Leukemia (2024) Vol. 38, Iss. 7, pp. 1626-1629
Open Access | Times Cited: 2
Sandra Huber, Natalie Wossidlo, Torsten Haferlach, et al.
Leukemia (2024) Vol. 38, Iss. 7, pp. 1626-1629
Open Access | Times Cited: 2
Molecular responses in decitabine- and decitabine/venetoclax-treated patients with acute myeloid leukemia and myelodysplastic syndromes
Agata Gruszczyńska, Abhishek Maiti, Christopher A. Miller, et al.
Haematologica (2024)
Open Access | Times Cited: 1
Agata Gruszczyńska, Abhishek Maiti, Christopher A. Miller, et al.
Haematologica (2024)
Open Access | Times Cited: 1
Can O-GIcNAc Transferase (OGT) Complex Be Used as a Target for the Treatment of Hematological Malignancies?
Shiwei Zhuang, Zhimei Liu, Jinyao Wu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 664-664
Open Access | Times Cited: 1
Shiwei Zhuang, Zhimei Liu, Jinyao Wu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 664-664
Open Access | Times Cited: 1
Emerging genetic technologies informing personalized medicine in SDS and other inherited bone marrow failure disorders
Alyssa Cull, David G. Kent, Alan J. Warren
Blood (2024) Vol. 144, Iss. 9, pp. 931-939
Closed Access | Times Cited: 1
Alyssa Cull, David G. Kent, Alan J. Warren
Blood (2024) Vol. 144, Iss. 9, pp. 931-939
Closed Access | Times Cited: 1
Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine—A prospective cohort study by the AGMT
Lisa Pleyer, Marc Vaisband, Manuel Drost, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 11, pp. 1685-1698
Open Access | Times Cited: 2
Lisa Pleyer, Marc Vaisband, Manuel Drost, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 11, pp. 1685-1698
Open Access | Times Cited: 2
Correlation between peripheral blood and bone marrow mutations among patients with Myelodysplastic Syndromes/Neoplasms from the National MDS Study
Amy E. DeZern, Johannes B. Goll, Travis L. Jensen, et al.
Deleted Journal (2024) Vol. 1, Iss. 3, pp. 100026-100026
Open Access
Amy E. DeZern, Johannes B. Goll, Travis L. Jensen, et al.
Deleted Journal (2024) Vol. 1, Iss. 3, pp. 100026-100026
Open Access
How I Manage Patients with Unexplained Cytopenia
Luca Malcovati, Mario Cazzola
Blood (2024)
Open Access
Luca Malcovati, Mario Cazzola
Blood (2024)
Open Access
